Learning deficits induced by chronic intraventricular infusion of quinolinic acid — protection by MK-801 and memantine

https://doi.org/10.1016/0014-2999(95)00682-6Get rights and content

Abstract

The NMDA receptor agonist quinolinic acid (9 mM) was infused i.c.v. via ALZET osmotic minipumps for 2 weeks. This treatment produced a persistent, short-term memory deficit in the T-maze. Autoradiography revealed a decrease in the density of choline uptake sites in the hippocampus. Parallel s.c. infusion by another minipump of the uncompetitive NMDA receptor antagonist memantine (1-amino-3,5-dimethyladamantane, 20 mg/kg per day) or (+)-5-methyl-10,11-dihydro-5H-dibenzocyclohepten-5,10-imine maleate ((+)-MK-801, 0.31 mg/kg day) prevented the learning deterioration induced by quinolinic acid. The treatment with memantine resulted in steady-state serum levels of 1.2 μM which, based on in vitro data, should assure inhibition of NMDA receptors and are similar to levels seen in the serum of demented patients treated with this agent. In naive animals this treatment had no effect on either learning or on ex vivo induction of long-term potentiation, indicating that under chronic conditions it is possible to obtain neuroprotective effects with NMDA receptor antagonists without negative effects on memory processes. This contrasts to some acute insults (e.g. ischaemia) where high doses of NMDA receptor antagonists that produce side effects are required.

References (46)

  • J.W. Ni et al.

    Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats

    Brain Res.

    (1994)
  • C.G. Parsons et al.

    Patch clamp studies on the kinetics and selectivity of N-methyl-d-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan)

    Neuropharmacology

    (1993)
  • M.A. Rogawski

    Therapeutic potential of excitatory amino acid antagonists — channel blockers and 2,3-benzodiazepines

    Trends Pharmacol. Sci.

    (1993)
  • B. Scatton

    Excitatory amino acid receptor antagonists: a novel treatment for ischemic cerebrovascular diseases

    Life Sci.

    (1994)
  • R. Spanagel et al.

    Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat — a pharmacokinetic microdialysis study

    Eur. J. Pharmacol.

    (1994)
  • Z. Susel et al.

    Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease

    Neurosci. Lett.

    (1991)
  • G.L. Wenk et al.

    Investigations of neurotoxicity and neuroprotection within the nucleus basalis of the rat

    Brain Res.

    (1994)
  • C.L. Willis et al.

    Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolinate-injected rat striatum

    Eur. J. Pharmacol.

    (1991)
  • K. Yamada et al.

    Neurotoxicity induced by continous infusion of quinolinic acid into the lateral ventricle in rats

    Neurosci. Lett.

    (1990)
  • M.F. Beal

    Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses

    Ann. Neurol.

    (1992)
  • M.F. Beal et al.

    Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

    J. Neurosci.

    (1993)
  • H.S.V. Chen et al.

    Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine — therapeutic advantage against NMDA receptor-mediated neurotoxicity

    J. Neurosci.

    (1992)
  • J.D. Clements et al.

    The time course of glutamate in the synaptic cleft

    Science

    (1992)
  • Cited by (0)

    View full text